Fig. 6.From: The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivoFullerenol NPs decrease blood and liver lipids in mice. Blood levels of TC (a) and TG (b), liver levels of TC (c) and TG (d), and representative hematoxylin and eosin staining of the liver (e) are shown. Bar = 50 μm. *P < 0.05, **P < 0.01, ***P < 0.001 vs NCBack to article page